Related references
Note: Only part of the references are listed.The endocannabinoid system impacts seizures in a mouse model of Dravet syndrome
Lyndsey L. Anderson et al.
NEUROPHARMACOLOGY (2022)
Evaluation of the Possible Anticonvulsant Effect of Δ9-Tetrahydrocannabinolic Acid in Murine Seizure Models
Melissa J. Benson et al.
CANNABIS AND CANNABINOID RESEARCH (2022)
Cannabichromene, Related Phytocannabinoids, and 5-Fluoro-cannabichromene Have Anticonvulsant Properties in a Mouse Model of Dravet Syndrome
Lyndsey L. Anderson et al.
ACS CHEMICAL NEUROSCIENCE (2021)
The Heat Sensing Trpv1 Receptor Is Not a Viable Anticonvulsant Drug Target in the Scn1a +/- Mouse Model of Dravet Syndrome
Vaishali Satpute Janve et al.
FRONTIERS IN PHARMACOLOGY (2021)
Activation of TRPV1 by Capsaicin or Heat Drives Changes in 2-Acyl Glycerols and N-Acyl Ethanolamines in a Time, Dose, and Temperature Dependent Manner
Meera Manchanda et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Cannabigerolic acid, a major biosynthetic precursor molecule in cannabis, exhibits divergent effects on seizures in mouse models of epilepsy
Lyndsey L. Anderson et al.
BRITISH JOURNAL OF PHARMACOLOGY (2021)
In vivo endocannabinoid dynamics at the timescale of physiological and pathological neural activity
Jordan S. Farrell et al.
NEURON (2021)
Genetic Manipulation of sn-1-Diacylglycerol Lipase and CB1 Cannabinoid Receptor Gain-of-Function Uncover Neuronal 2-Linoleoyl Glycerol Signaling in Drosophila melanogaster
Giuseppe Tortoriello et al.
CANNABIS AND CANNABINOID RESEARCH (2021)
Elevated Levels of Arachidonic Acid-Derived Lipids Including Prostaglandins and Endocannabinoids Are Present Throughout ABHD12 Knockout Brains: Novel Insights Into the Neurodegenerative Phenotype
Emma Leishman et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2019)
Coadministered cannabidiol and clobazam: Preclinical evidence for both pharmacodynamic and pharmacokinetic interactions
Lyndsey L. Anderson et al.
EPILEPSIA (2019)
2-Linoleoylglycerol Is a Partial Agonist of the Human Cannabinoid Type 1 Receptor that Can Suppress 2-Arachidonolyglycerol and Anandamide Activity
Leanne Lu et al.
CANNABIS AND CANNABINOID RESEARCH (2019)
Control of excessive neural circuit excitability and prevention of epileptic seizures by endocannabinoid signaling
Yuki Sugaya et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2018)
Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System
Shenglong Zou et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Endocannabinoid dysregulation in cognitive and stress-related brain regions in the Nrg1 mouse model of schizophrenia
David J. Clarke et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2017)
Screening of conventional anticonvulsants in a genetic mouse model of epilepsy
Nicole A. Hawkins et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2017)
Targeting brain and peripheral plasticity of the lipidome in acute kainic acid-induced epileptic seizures in mice via quantitative mass spectrometry
Raissa Lerner et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2017)
The anti-inflammatory mediator palmitoylethanolamide enhances the levels of 2-arachidonoyl-glycerol and potentiates its actions at TRPV1 cation channels
Stefania Petrosino et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
Impaired 2-AG Signaling in Hippocampal Glutamatergic Neurons: Aggravation of Anxiety-Like Behavior and Unaltered Seizure Susceptibility
Stephan Guggenhuber et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2016)
Where's my entourage? The curious case of 2-oleoylglycerol, 2-linolenoylglycerol, and 2-palmitoylglycerol
Natalia Murataeva et al.
PHARMACOLOGICAL RESEARCH (2016)
Broad impact of deleting endogenous cannabinoid hydrolyzing enzymes and the CB1 cannabinoid receptor on the endogenous cannabinoid-related lipidome in eight regions of the mouse brain
Emma Leishman et al.
PHARMACOLOGICAL RESEARCH (2016)
Endocannabinoids and endocannabinoid-related mediators: Targets, metabolism and role in neurological disorders
Fabio Arturo Iannotti et al.
PROGRESS IN LIPID RESEARCH (2016)
Transient increase of interleukin-1β after prolonged febrile seizures promotes adult epileptogenesis through long-lasting upregulating endocannabinoid signaling
Bo Feng et al.
SCIENTIFIC REPORTS (2016)
Age-related changes in the endocannabinoid system in the mouse hippocampus
Anastasia Piyanoya et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2015)
Weeding out bad waves: towards selective cannabinoid circuit control in epilepsy
Ivan Soltesz et al.
NATURE REVIEWS NEUROSCIENCE (2015)
Mapping genetic modifiers of survival in a mouse model of Dravet syndrome
A. R. Miller et al.
GENES BRAIN AND BEHAVIOR (2014)
Brain region-specific changes in N-acylethanolamine contents with time of day
Elizabeth Sabens Liedhegner et al.
JOURNAL OF NEUROCHEMISTRY (2014)
Distinct modulation of the endocannabinoid system upon kainic acid-induced in vivo seizures and in vitro epileptiform bursting
Filomena Fezza et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2014)
Changes in the cannabinoid (CB1) receptor expression level and G-protein activation in kainic acid induced seizures
Engin Bojnik et al.
EPILEPSY RESEARCH (2012)
Cerebrospinal fluid levels of the endocannabinoid anandamide are reduced in patients with untreated newly diagnosed temporal lobe epilepsy
Andrea Romigi et al.
EPILEPSIA (2010)
Monoacylglycerols activate capsaicin receptor, TRPV1
Yusaku Iwasaki et al.
LIPIDS (2008)
Endocannabinoid signaling as a synaptic circuit breaker in neurological disease
Istvan Katona et al.
NATURE MEDICINE (2008)
Quantitative profiling of endocannabinoids and related compounds in rat brain using liquid chromatography-tandem electrospray ionization mass spectrometry
Denise Richardson et al.
ANALYTICAL BIOCHEMISTRY (2007)
Prevention of plasticity of endocannabinoid signaling inhibits persistent limbic hyperexcitability caused by developmental seizures
Kang Chen et al.
JOURNAL OF NEUROSCIENCE (2007)
The endocannabinoid system controls key epileptogenic circuits in the hippocampus
Krisztina Monory et al.
NEURON (2006)
Differential diurnal variations of anandamide and 2-arachidonoyl-glycerol levels in rat brain
M Valenti et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2004)
Inhibition of monoacylglycerol lipase and fatty acid amide hydrolase by analogues of 2-arachidonoylglycerol
N Ghafouri et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain
T Bisogno et al.
JOURNAL OF CELL BIOLOGY (2003)
CB1 cannabinoid receptors and on-demand defense against excitotoxicity
G Marsicano et al.
SCIENCE (2003)
The endogenous cannabinoid system regulates seizure frequency and duration in a model of temporal lobe epilepsy
MJ Wallace et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Long-term plasticity of endocannabinoid signaling induced by developmental febrile seizures
K Chen et al.
NEURON (2003)
The general anesthetic propofol increases brain N-arachidonylethanolamine (anandamide) content and inhibits fatty acid amide hydrolase
S Patel et al.
BRITISH JOURNAL OF PHARMACOLOGY (2003)
Share Paper
